Key opinion leader in the field of Diabetic Medicine, Dr. Amy Mottl speaks on PromarkerD and the utility of predicting diabetic kidney disease.

Dr Amy Mottl, MD, MPH, FASN, Associate Professor of Medicine, Division of Nephrology and Hypertension. Dr Mottl specialises in Epidemiology and Pathogenesis of Diabetic Kidney Disease.

For more information on PromarkerD, visit